Personal profile


Sharon is the Head of the new provisional Centre for Research in Mechanisms of Disease and Drug Design, in the School of Life and Medical Sciences. The Centre integrates the university's scientific expertise in the understanding of health and disease, and the design of new therapeutic strategies.

Sharon is a synthetic and medicinal chemist, with extensive research experience in the development of novel small molecules applied to understanding and treating disease.

Sharon obtained her PhD in the synthesis of natural product analogues to treat parasitic diseases, followed by postdoctoral experience in the areas of cancer pro-drug design and cardiovascular mechanisms, before joining the University in 2005.


Research interests

Medicinal and biological chemistry, drug design and synthesis. Cancer drug targets and drug design. Antiobiotic-restoring peptides to combat antimicrobial resistance. Natural product analogues with anti-inflammatory properties. Small molecule cardiovascular system probes. Novel synthetic technologies.

Teaching specialisms

Organic and medicinal chemistry. Integration of science and clinical aspects of pharmacy; relating structure and functions of medicines to their clinical use.

Education/Academic qualification

Chemistry, BSc, King's College London

PhD, Synthesis of quinolines with anthelmintic activity, King's College London


Dive into the research topics where Sharon Rossiter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or